Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Phosphorylation/Dephosphorylation<br />
Product Cat. No. Comments Size Price<br />
JAK <strong>Inhibitor</strong> I 420099 {2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one}<br />
A potent inhibitor of Janus protein tyrosine Kinases (JAKs). Displays potent inhibitory<br />
activity against JAK (IC 50 = 5 nM for murine JAK ), JAK2 (IC 50 = nM), JAK3 (K i =<br />
5 nM), and Tyk2 (IC 50 = nM).<br />
N InSolution JAK<br />
<strong>Inhibitor</strong> I<br />
420097 {2-(1,1-Dimethylethyl)-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinolin-7-one}<br />
A 0 mM (500 mg/ 62 ml) solution of JAK <strong>Inhibitor</strong> I (Cat. No. 420099) in DMSO.<br />
N JAK2 <strong>Inhibitor</strong> II 420132 (1,2,3,4,5,6-Hexabromocyclohexane)<br />
A cell-permeable hexabromocyclohexane compound that acts as a specific and direct<br />
inhibitor of JAK2 autophosphorylation (maximal inhibition at 50 mM in BSC-40 cells<br />
overexpressing JAK2).<br />
JAK3 <strong>Inhibitor</strong> I 420101 [4-(4´-Hydroxyphenyl)amino-6,7-dimethoxyquinazoline; WHI-P131]<br />
A specific inhibitor of JAK3 (IC 50 = 78 mM). Does not affect the activity of JAK , JAK2,<br />
ZAP/Syk, or Src tyrosine kinases.<br />
JAK3 <strong>Inhibitor</strong> II 420104 {4-[(3´-Bromo-4´-hydroxyphenyl)amino]-6,7-dimethoxyquinazoline; WHI-P154}<br />
A potent, cell-permeable inhibitor of JAK3 that is reported to kill glioblastoma cells<br />
(IC 50 = 8 3 nM).<br />
JAK3 <strong>Inhibitor</strong> III 420106 [4-(3´,5´-Dibromo-4-hydroxyphenyl)amino-6,7-dimethoxyquinazoline; WHI-P97]<br />
A potent and specific inhibitor of JAK3 (IC 50 = mM).<br />
JAK3 <strong>Inhibitor</strong> IV 420121 [2-Naphthyl-(N-isopropyl,N-benzyl)-b-aminoethylketone, HCI; ZM 39923]<br />
A potent and selective ATP-competitive inhibitor of JAK3 (pIC 50 = 7. ). Weakly inhibits<br />
other tyrosine kinases (pIC 50 = 5.6 for EGF-R; 4.4 for JAK ). In neutral buffer undergoes<br />
a retro-Michael breakdown (t /2 = 36 min at 25˚C, pH 7.43) to the active analog 2-naphthylvinyl<br />
ketone (Cat. No. 420 22) [pIC 50 = 6.8 for JAK3; 5.0 for EGF-R; 4.7 for JAK ].<br />
JAK3 <strong>Inhibitor</strong> V 420122 [(2-Naphthylvinyl Ketone); ZM 449829]<br />
A breakdown product of JAK3 <strong>Inhibitor</strong>-IV (Cat. No. 420 2 ) with similar inhibitory<br />
activities (pIC 50 = 6.8 for JAK3; 5.0 for EGF-R; 4.7 for JAK ). Also inhibits STAT-5<br />
phosphorylation and T-cell proliferation.<br />
JAK3 <strong>Inhibitor</strong> VI 420126 A cell-permeable, potent inhibitor of JAK3 (IC 50 = 27 nM). Binds to the enzyme active<br />
site and prevents IL-2-induced cellular phosphorylation of JAK3 and STAT5.<br />
JAK3 <strong>Inhibitor</strong>, Negative<br />
Control<br />
420112 (4-Phenylamino-6,7-dimethoxyquinazoline; WHI-P258)<br />
A useful negative control compound for JAK3 inhibitors.<br />
Lavendustin A 428150 {5-Amino-[(N-2,5-dihydroxybenzyl)-N´-2-hydroxybenzyl]salicylic Acid; RG14355}<br />
A potent inhibitor of EGFR kinase (IC 50 = nM) and p60 c-src (IC 50 = 500 nM).<br />
Lavendustin B 428160 [5-Amino-(N,N´-bis-2-hydroxybenzyl)salicylic Acid]<br />
A negative control for Lavendustin A (IC 50 = .3 mM for EGFR kinase).<br />
Lavendustin C 234450 [Compound 5; 5-(N-2´,5´-Dihydroxybenzyl)aminosalicylic Acid]<br />
Potent inhibitor of p60c-src (IC = 200 nM) and Ca 50 2+ /calmodulin-dependent kinase II<br />
(IC = 200 nM).<br />
50<br />
N Lck <strong>Inhibitor</strong> 428205 A cell-permeable pyrrolopyrimidine compound that acts as a potent, selective and ATPcompetitive<br />
inhibitor of Lck (IC at 5 mM of ATP = < nM, 2 nM, 70 nM, .57 mM, and<br />
50<br />
.98 mM for Lck Y 64-509 394 , lckcd pY394 , src, kdr, and tie-2, respectively; IC at mM of<br />
50<br />
ATP = 6 nM, 66 nM, 26 nM, 420 nM, and 5. 8 mM for Lck Y 64-509 394 , blk, fyn, lyn, and<br />
csk, respectively). Only minimally affects the activities of other kinases (IC = 3.2 mM,<br />
50<br />
> 33 mM, > 50 mM, and > 50 mM for EGFR, PKC, CDC2/B, and ZAP-70, respectively).<br />
N<br />
Protein Tyrosine Kinase (PTK) <strong>Inhibitor</strong>s, continued<br />
LFM-A 435301 [a-Cyano-b-hydroxy-b-methyl-N-(3-fluorophenyl)propenamide]<br />
A useful negative control (IC 50 ≥ 454 mM) for LFM-A 3.<br />
LFM-A 2 435302 {a-Cyano-b-hydroxy-b-methyl-N-[4-(trifluoromethoxy)phenyl]propenamide}<br />
A potent and specific inhibitor of EGFR kinase (IC 50 = .7 mM).<br />
LFM-A 3 435300 [a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide]<br />
A potent and specific inhibitor of Bruton’s tyrosine kinase (BTK; IC 50 = 7.2 mM for human<br />
BTK in vitro and IC 50 = 2.5 mM for recombinant BTK).<br />
Met Kinase <strong>Inhibitor</strong> 448101 (3Z)-N-(3-Chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1Hpyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide;<br />
SU11274<br />
A cell-permeable pyrrole indolinone compound that acts as a potent, reversible, and<br />
ATP-competitive inhibitor of Met kinase activity (IC = 20 nM).<br />
50<br />
500 mg $83<br />
500 mg $83<br />
25 mg $88<br />
5 mg $ 8<br />
5 mg $ 50<br />
mg $ 27<br />
0 mg $ 90<br />
0 mg $ 68<br />
5 mg $ 5<br />
50 Orders Phone 800 854 34 7<br />
Calbiochem • <strong>Inhibitor</strong> SourceBook<br />
Fax 800 776 0999<br />
Web www.emdbiosciences.com/calbiochem<br />
500 mg<br />
mg<br />
500 mg<br />
mg<br />
500 mg<br />
mg<br />
$76<br />
$ 27<br />
mg $ 7<br />
mg $ 7<br />
mg $62<br />
mg $82<br />
$44<br />
$75<br />
$ 42<br />
$230<br />
5 mg $98<br />
mg $85